No Data
No Data
Xintong Medical-B (02160.HK): Revenue of 336 million yuan in 2023 increased by 33.9% year-on-year
Gelonghui, March 27 | Xintong Medical-B (02160.HK) announced that for the year ended December 31, 2023, revenue was approximately RMB 336 million, up 33.9% year on year; gross profit was approximately RMB 230 million, up 41.8% year on year; loss attributable to the company's equity shareholders was approximately RMB 472 million; loss attributable to the company's equity shareholders was approximately RMB 454 million; basic loss per share.
Xintong Medical-B (02160) announced its 2023 annual results. Shareholders should account for losses of 472 million yuan, and losses increased by 3.8%
According to the Zhitong Finance App, Xintong Medical-B (02160) announced the results for the year ended December 31, 2023. The group recorded revenue of 336 million yuan, an increase of 33.9% over the previous year. The company's equity shareholders should have accounted for a loss of 472 million yuan, an increase of 3.8%, and a loss of 0.2 yuan per share. According to the report, the 33.9% increase in revenue was mainly due to the rapid increase in the number of surgeries brought about by the increase in the number of admissions of the Group's TAVI products in China, which increased sales of the Group's TAVI products in China. Meanwhile, in 2023, with the Group's TAVI products being sold overseas
CARDIOFLOW-B: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023
Xintong Medical-B (02160.HK) will hold a board meeting on March 27 to approve the annual results
Gelonghui March 15 | Xintong Medical-B (02160.HK) issued an announcement. The company's board of directors meeting will be held on March 27, 2024 to review and approve the Group's annual results and announcements for the year ended December 31, 2023, and consider the proposal to pay a final dividend (if any).
CARDIOFLOW-B: DATE OF BOARD MEETING
Changes in Hong Kong stocks | Xintong Medical-B (02160) rose more than 7% and is expected to increase revenue by about 31% to 36% year-on-year last year
Xintong Medical-B (02160) rose more than 7%. As of press release, it rose 7.46% to HK$1.44, with a turnover of HK$3.685,400.
No Data